Radial Approach, 1st choice in Acute Coronary Syndromes

Original title: Radial Versus Femoral Randomized Investigation in ST-Segment Elevation Acute Coronary síndrome. The RIFLE-STEACS (Radial Versus Femoral Randomized Investigation in ST-Elevation Acute Coronary Syndrome) Study. Reference: Enrico Romagnoli et al. J Am Coll Cardiol 2012;60:2481–9.

Bleeding in patients with acute coronary syndromes (ACS) is an independent predictor of morbidity and mortality. Until today, evidence supporting the radial approach came from studies not strong enough to show significant difference in hard clinical end points.

This multicenter study included 1001 patients with ST segment elevation ACS randomized 1:1, radial vs. femoral. All patients were positive for Allen’s tested in both hands and operators were required that at least a 50% of performed angioplasty procedures by radial approach.

Primary end point was a composite between cardiac death, infarction, stroke, revascularization and non surgical bleeding, Baseline characteristics were well balanced, around 10% were in Killip class III/IV, and 8%required intra-aortic balloon counterpulsation. There were no differences in symptom/balloon time and door/balloon time between the groups. The overall rate of vascular approach crossover was 6.1%.

The primary end point was significantly lower in the radial group compared to the femoral (13.6% vs. 21% p=0.003). Cardiac death was also significantly lower in the radial group (5.2% vs. 9.2% p=0.02) and there were no differences in infarction (1.2% vs. 1.4% p=1), revascularization (1.2% vs. 1.8% p=0.6) or stroke occurrence (0.8% vs. 0.6% p=0.72).

Bleeding occurred in 10% of procedures and was lower in the radial group (7.8% vs. 12.2% p=0.026); this difference was due to a reduction of 60% in bleeding associated to access site. Non surgical bleeding was 53% of all bleeding and was similar in both groups (5.2% vs. 5.4% p=1).

Using TIMI criteria, no differences were observed in major bleeding but differences were noted in minor bleeding (radial 4% vs. femoral 7.2% p=0.038). Hospitalization was also significantly lower for those accessed by radial approach.

Conclusion 

The RIFLE-STEACS trial clearly shows the advantages of the radial approach vs. the femoral approach in patients with ST segment elevation ACS.

Editorial Comment:

This is the first study with enough statistical strength to show different in hard clinical end points to make the radial approach the number one choice, also in the emergency room. The low frequency use of Bivalirudin (a mere 8%, a more frequent use may reduce the gap in terms of bleeding), and operator training were study limitations.

Though the radial approach significantly reduces bleeding and mortality, bleeding events not associated with access sites are still 53%. We should use the radial approach but also assess patients with bleeding risk scores (e.g. CRUSADE) to adjust antiplatelet and antithrombotics on a case by case basis. 

SOLACI.ORG

More articles by this author

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Chronic Stent Recoil and Its Long-Term Effects

The evolution of stent technology—including new scaffold designs, thinner struts, and more biocompatible polymers—has brought about an emerging concern: the late loss of structural...

PROSPECT II Substudy: Relationship Between Different Levels of hs-CRP and Vulnerable Plaque Characteristics in Patients with NSTEMI

Inflammation plays a key role in the onset and progression of atherosclerosis and has been linked to a higher risk of cardiovascular events, regardless...

Aspirin vs. Clopidogrel Monotherapy After 1 Month of ACS: Subgroup Analysis Based on Bleeding Risk and MI Type

Current guidelines still recommend dual antiplatelet therapy (DAPT) for 12 months following percutaneous coronary intervention (PCI) as the standard treatment in patients with acute...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Polymer-Free vs. Biodegradable Polymer Stents: SORT OUT IX 5-Year Outcomes

In a constant strive to achieve life time management, interventional cardiologists focus on optimizing coronary scaffolds, which calls for the development of devices with...

Three-Year Outcomes of Mitral Valve-in-Valve Therapy with Balloon-Expandable Valves in the United States

Gentileza del Dr. Juan Manuel Pérez. Mitral Valve-in-Valve (MViV) implantation with balloon-expandable valves has become a solid alternative for patients with degenerated mitral bioprostheses. However,...

Edge-to-Edge Treatment in Cardiogenic Shock

Cardiogenic shock (CS) is characterized by severe ventricular dysfunction, most often of ischemic origin. It is frequently associated with severe mitral regurgitation (MR), either...